DPP4 and osteoporosis: Evidence exists in the literature that DPP4 has been identified as a novel protease playing crucial roles in the development of dyslipidemia, inflammation, and insulin resistance, all of which have been suggested to be involved in the pathogenesis of osteoporosis [18].